The emergence of Avian Influenza A(H9N2) in Vietnam requires an urgent call for vigilance and preparedness

• Ramisa Anjum
• Khan S.R.
• Siddiqui U.A.
• Dewan S.M.R.

Abstract

In response to the recent case of avian influenza A(H9N2) in Vietnam, it is vital to recognize the broader implications posed by avian viruses for public health. While the infected individual receives medical treatment, there is no evidence of human-to-human transmission further in Vietnam, easing immediate concerns. However, it is essential to consider such risks seriously and start precautionary measures beforehand due to their high frequency in bird populations, especially in Vietnam, their potential for zoonotic infections, their continual evolution, and the accumulation of mutations indicative of adaption to humans. However, this incident underscores the ongoing threat posed by avian influenza viruses, particularly in regions where they are endemic. Though H9N2 typically causes mild illness in humans, it has the potential to mutate and acquire the capability for sustained transmission, potentially leading to a pandemic. Strengthening surveillance, rapid response protocols, and promoting research to develop effective vaccines and antiviral drugs are crucial to prevent and control future outbreaks. By prioritizing these measures and bolstering global cooperation, we can better address the threats posed by avian influenza viruses like H9N2.

Keywords:avian influenza; H9N2; Vietnam; pandemic; vaccine development; zoonotic infections; surveillance; genetic sequencing; biosecurity; global collaboration

References

1. World Health Organization. Avian Influenza A(H9N2) – Viet Nam. URL: https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON514 (date of accessed April 22, 2024).

2. Homme P., Easterday B. Avian influenza virus infections. I. Characteristics of influenza A – Turkey – Wisconsin – 1966 virus. Avian Dis. 1970; 14 (1): 66–74.

3. Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam. PLoS One. 2012; 7 (8): e43948.

4. Almayahi Z.K., Al Kindi H., Davies C.T., et al. First report of human infection with avian influenza A (H9N2) virus in Oman: the need for a One Health approach. Int J Infect Dis. 2020; 91: 169–73.

5. Zhang J., Huang L., Liao M., Qi W. H9N2 avian influenza viruses: challenges and the way forward. Lancet Microbe. 2023; 4 (2): e70–1.

6. Centers for Disease Control and Prevention. Vietnam Reports First Human Infection with Avian Influenza H9N2 Virus. Updated April 12, 2024. URL: https://www.cdc.gov/flu/avianflu/spotlights/2023-2024/vietnam-human-infection.htm (date of access April 22, 2024).

7. Song W., Qin K. Human-infecting influenza A (H9N2) virus: a forgotten potential pandemic strain? Zoonoses Public Health. 2020; 67 (3): 203–12.

8. Liu Y., Zhao D., Zhang J., et al. Development of an inactivated avian influenza virus vaccine against circulating H9N2 in chickens and ducks. Vaccines. 2023; 11 (3): 596.

9. Dong J., Zhou Y., Pu J., Liu L. Status and challenges for vaccination against avian H9N2 influenza virus in China. Life. 2022; 12 (9): 1326.

10. Sun Y., Yang C., Li J., et al. Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks. Arch Virol. 2017; 162: 171–9.

11. Centers for Disease Control and Prevention. Types of Influenza Viruses. Updated March 30. 2023. URL: https://www.cdc.gov/flu/about/viruses/types.htm#:~:text=Influenza%20A%20viruses%20are%20the,have%20little%20or%20no%20immunity (date of access April 22, 2024).

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)